Cargando…

Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes

OBJECTIVE: The associated risk of vascular disease following diagnosis of type 2 diabetes in people previously identified as having pre-diabetes in real-world settings is unknown. We examined the presence of microvascular and macrovascular disease in individuals with newly diagnosed type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palladino, Raffaele, Tabak, Adam G, Khunti, Kamlesh, Valabhji, Jonathan, Majeed, Azeem, Millett, Christopher, Vamos, Eszter P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202749/ https://www.ncbi.nlm.nih.gov/pubmed/32332069 http://dx.doi.org/10.1136/bmjdrc-2019-001061

Ejemplares similares

Evaluation of the Diabetes Screening Component of a National Cardiovascular Risk Assessment Programme in England: a Retrospective Cohort Study
por: Palladino, Raffaele, et al.
Publicado: (2020)

Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
por: Vamos, Eszter Panna, et al.
Publicado: (2012)

Ethnic Differences in Diabetes Management in Patients With and Without Comorbid Medical Conditions: A cross-sectional study
por: Alshamsan, Riyadh, et al.
Publicado: (2011)

Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes
por: An, Jaejin, et al.
Publicado: (2021)

Changes in the Incidence of Lower Extremity Amputations in Individuals With and Without Diabetes in England Between 2004 and 2008
por: Vamos, Eszter P., et al.
Publicado: (2010)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Impact of Pay for Performance on Ethnic Disparities in Intermediate Outcomes for Diabetes: A Longitudinal Study
por: Millett, Christopher, et al.
Publicado: (2009)

Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic Retinopathy
por: Wykoff, Charles C., et al.
Publicado: (2021)

Medication adherence and glycemic control among newly diagnosed diabetes patients
por: Lin, Lee-Kai, et al.
Publicado: (2017)

Ethnic Disparities in Diabetes Management and Pay-for-Performance in the UK: The Wandsworth Prospective Diabetes Study
por: Millett, Christopher, et al.
Publicado: (2007)

Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study
por: Misra, Shivani, et al.
Publicado: (2021)

Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit
por: Holman, Naomi, et al.
Publicado: (2022)

Thirty-Year Trends in Complications in U.S. Adults With Newly Diagnosed Type 2 Diabetes
por: Fang, Michael, et al.
Publicado: (2021)

Time to Development of Overt Diabetes and Macrovascular and Microvascular Complications Among Patients With Prediabetes: A Retrospective Cohort Study
por: Finocchio, Tyler, et al.
Publicado: (2021)

Fasting Plasma C-Peptide and Micro- and Macrovascular Complications in a Large Clinic-Based Cohort of Type 1 Diabetic Patients
por: Panero, Francesco, et al.
Publicado: (2009)

Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis
por: Aikaeli, Faith, et al.
Publicado: (2022)

Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study
por: Barron, Emma, et al.
Publicado: (2020)

Nationwide Study on Trends in Hospital Admissions for Major Cardiovascular Events and Procedures Among People With and Without Diabetes in England, 2004–2009
por: Vamos, Eszter P., et al.
Publicado: (2012)

Diabetes and the COVID-19 pandemic
por: Khunti, Kamlesh, et al.
Publicado: (2022)

Prevalence of Microvascular Complications in Newly Diagnosed Patients with Type 2 Diabetes
por: Ali, Alia, et al.
Publicado: (2013)

Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus
por: García-Ulloa, Ana Cristina, et al.
Publicado: (2021)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Sun, Bao, et al.
Publicado: (2021)

Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study
por: Lai, Heidi T. M., et al.
Publicado: (2023)

Temporal Trends in Lower-Limb Major and Minor Amputation and Revascularization Procedures in People With Diabetes in England During the COVID-19 Pandemic
por: Valabhji, Jonathan, et al.
Publicado: (2021)

Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009–2018: a retrospective cohort study
por: Pal, Kingshuk, et al.
Publicado: (2021)

Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
por: Pintat, Stéphane, et al.
Publicado: (2019)

Osteopontin for Early Detection of Microvascular and Macrovascular Type 1 Diabetic Complication
por: El Dayem, Soha M. Abd, et al.
Publicado: (2019)

Predicting Macro- and Microvascular Complications in Type 2 Diabetes: The Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine
por: Tanaka, Shiro, et al.
Publicado: (2013)

COVID-19 presents opportunities and threats to transport and health
por: Laverty, Anthony A, et al.
Publicado: (2020)

Associations between attainment of incentivized primary care indicators and incident lower limb amputation among those with type 2 diabetes: a population-based historical cohort study
por: Gunn, Laura H, et al.
Publicado: (2021)

Medication burden in the first 5 years following diagnosis of type 2 diabetes: findings from the ADDITION-UK trial cohort
por: Black, James A, et al.
Publicado: (2015)

Risk of Macrovascular and Microvascular Disease in Diabetes Diagnosed Using Oral Glucose Tolerance Test With and Without Confirmation by Hemoglobin A1c: The Whitehall II Cohort Study
por: Tabák, Adam G., et al.
Publicado: (2022)

Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004–2014
por: Laverty, Anthony A., et al.
Publicado: (2017)

Effect of Glycemic Treatment and Microvascular Complications on Menopause in Women With Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort
por: Kim, Catherine, et al.
Publicado: (2014)

Bimodal Distribution of Glucose Is Not Universally Useful for Diagnosing Diabetes
por: Vistisen, Dorte, et al.
Publicado: (2009)

New directions in incidence and prevalence of diagnosed diabetes in the USA
por: Benoit, Stephen R, et al.
Publicado: (2019)

Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)
por: Herman, William H., et al.
Publicado: (2015)

Endothelium in Coronary Macrovascular and Microvascular Diseases
por: Godo, Shigeo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0q9n3hm71hsfrka4ubc6vgkr02